Dear CPOCT Symposium Registrant,

As a proud supporter of AACC’s mission and values, and as a sponsor of the CPOCT International Symposium since 2000, Nova Biomedical is excited to participate in this year’s meeting focusing on the role of point-of-care testing in clinical decision making and improved patient outcomes.

As a world leader in critical care and point-of-care and diagnostics, Nova Biomedical develops analysers with the most advanced blood testing technology to improve patient outcomes and reduce costs. Whether testing is performed in emergency, surgical, critical, or respiratory care areas, Nova analysers offer the most extensive stat test menus and deliver results in the shortest time to support hospitalized patients.

Nova analysers were used in 30 collaborator studies appearing in this year’s poster sessions—four of which have been selected for oral presentations.

Visit Nova Biomedical representatives at AACC CPOCT or www.novabiomedical.com to learn more about the following point-of-care and critical care analysers.

Stat Profile® Prime	StatStrip® Glucose
POC analyser offering multiple test menus for critical care, electrolytes, and more, and featuring ZERØ™ maintenance cartridge technology and automated, on-board, external liquid QC	The only glucose meter FDA-cleared for use with critically ill patients and with no clinical interferences

StatStrip® Lactate	StatSensor® Creatinine
Rapid, POC lactate testing for sepsis screening and therapy monitoring, and for foetal scalp lactate	Rapid, POC kidney function screening

Allegro™ Rapid, simple, POC capillary analyser with a 14-test primary care menu CE mark pending